10

News Archive

2008-11-18
Job opportunity: BMA
 

2008-05-08
Heparin from Carmeda is not contaminated
Heparin from Carmeda is not contaminated In response to the Medtronic News  Release dated May 7, 2008 regarding a voluntary and precautionary recall of selected products featuring the...

2007-07-05
Carmeda Newsletter, July 2007
Summarized latest news about Carmeda® BioActive Surface coated applications and related publications.

2007-04-20
Substantial bioactivity after 855 days of use
A Berlin Heart Ventricular Assist Device (EXCOR) explant showed that approximately 50% of the initial surface heparin bioactivity is retained on the surface after 855 days of use in a patient. Dr...

2006-12-13
New website launched!
Carmeda has today launched its new redesigned website. The new site has been given a new exciting look and the improved structure will make it easier to find the information you want...

2006-11-17
FDA clears GORE PROPATEN Vascular Graft
The U.S. Food & Drug Administration (FDA) has given W. L. Gore & Associates, Inc. (GORE) clearance to market its GORE PROPATEN Vascular Graft for peripheral use, including lower-limb...

2006-11-16
Spire Decathlon™ Gold officially launched
Spire Biomedical introduces an innovative new product at the ASN conference in San Diego November 15 - 19: the Decathlon Gold End-Point™ Bonded heparin coated catheter, which received market...

Carmeda AB is a fully owned subsidiary of W.L. Gore & Associates, Inc. The content of this site is © Carmeda 2008, all rights reserved.
Legal & Privacy policy | Trademarks | Webbdesign by Sphinxly, Content management by easyWeb publiceringsverktyg